Document is current
Any future updates will be listed below
-
Authors
Serrar, Yasmine
Sejournet, Lucas
Allignet, Benoît
Bounetta, Sami
Deiri, Marwa
Gullon, Chloé
Malclès, Ariane
Denis, Philippe
Mathis, Thibaud
Kodjikian, Laurent
- License Information
-
More Information
Article History
Received: 11 December 2025
Accepted: 4 February 2026
First Online: 1 March 2026
Declarations
:
: Yasmine Serrar, Lucas Sejournet, Benoît Allignet, Sami Bounetta, Marwa Deiri, and Chloé Gullon have no conflict of interest to report. Laurent Kodjikian is consultant for AbbVie, Alimera, Bayer, Celltrion, MS-Pharma, Krys, Horus, Novartis, and Roche. Thibaud Mathis is consultant for AbbVie, Bayer, GSK, Horus, Kol, Novartis, and Roche. Philippe Denis is a consultant for AbbVie and Horus. Ariane Malclès is a consultant for Bayer and Roche.
: This research was conducted in accordance with the Declaration of Helsinki. Patients' informed consent was obtained, and the local ethics committee (Hospices Civils de Lyon) approved the study, registered under number 20-156.
